Showing 1 - 6 of 6 results
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Sulazepam is a desmethylbenzodiazepine. It is the thioamide derivative of diazepam. It has sedative, muscle relaxant, hypnotic, anticonvulsant and anxiolytic properties like those of other benzodiazepines. Sulazepam in vivo in experimental animals un...
Setipafant [BN 50727], triazolothienodiazepine, is a synthetic platelet activating factor antagonist that was under development with Beaufour-Ipsen for the treatment of diarrhoea, inflammatory bowel diseases, peptic ulcer and ulcerative colitis. The ...
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
Fandofloxacin is a difluoroquinolone derivative. This compound possesses an antibacterial spectrum comparable to those of rufloxacin and ciprofloxacin in vivo. Fandofloxacin showed a rapid and nearly complete absorption, and a long residence time in ...
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
Dazmegrel [UK 38485] is a thromboxane synthetase inhibitor which was undergoing development in the treatment of thrombosis, ischaemic heart disease, arrhythmias and asthma. Pfizer were conducting phase II studies in Denmark and the UK, phase I studie...
Information related to the biological and/or pharmacological activity of glyoctamide is absence. Only one mention exists, describing, that this compound was developed as the antidiabetic agent by Hoechst Roussel Pharm. Inc
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
Fandofloxacin is a difluoroquinolone derivative. This compound possesses an antibacterial spectrum comparable to those of rufloxacin and ciprofloxacin in vivo. Fandofloxacin showed a rapid and nearly complete absorption, and a long residence time in ...